Company profile: RCT Logic
1.1 - Company Overview
Company description
- Provider of clinical trial design development and licensing for trials sponsored by industry, non-profit entities, and U.S. state governments, including the Sequential Parallel Comparison Design (SPCD) to reduce the detrimental impact of placebo response and address the placebo response problem.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RCT Logic
Arxspan
HQ: United States
Website
- Description: Provider of a platform-independent suite of applications with US cloud-based web-delivery for project based research and development collaboration in the pharmaceutical, biotechnology, or chemistry industry, enabling tracking of internal research, management of incoming CRO data, and integration with existing enterprise knowledge management tools via a web-based user interface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arxspan company profile →
Cryoport
HQ: United States
Website
- Description: Provider of outsourced temperature-controlled shipping and logistics for biological materials, offering ISO 21973-compliant shipping systems across cryogenic, ultra-cold (dry ice), refrigerated and controlled room temperatures; IntegriCell cryopreservation; integrated BioServices and biostorage; consulting to de-risk biologics and cell & gene therapy supply chains; and comprehensive upstream/downstream supply chain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoport company profile →
Transition Bio
HQ: United States
Website
- Description: Provider of condensate technology for drug discovery and diagnostics, offering PhaseScanTM, a microfluidics-based high-throughput molecular screen to identify drug candidates and mechanisms of action; CelPhaseTM, high-content cellular imaging to visualize condensates in disease models and patient samples for target validation; and DeePhaseTM, an AI engine using proprietary datasets for target discovery and hit identification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transition Bio company profile →
Eureka Genomics
HQ: United States
Website
- Description: Provider of Next Generation Sequencing and gene annotation services and diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops. Offerings include detection of foreign nucleic acids, sequence data analysis, resequencing and mapping, platform-agnostic genotyping of SNPs, InDels, CNV, methylation, barley and bovine SNP panels, custom NGG assay design, and NGS for CE sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eureka Genomics company profile →
Tahoe Bio
HQ: United States
Website
- Description: Provider of AI-powered tools that simulate human cell responses to guide drug discovery, including Mosaic for generating large-scale single-cell datasets and high-resolution in vivo phenotypic and transcriptomic profiling, single-cell RNA pooling to analyze drug action across diverse patients, and in vivo drug-cell interaction studies; initial applications in oncology; open-sources the Tahoe-100M dataset.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tahoe Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RCT Logic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RCT Logic
2.2 - Growth funds investing in similar companies to RCT Logic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RCT Logic
4.2 - Public trading comparable groups for RCT Logic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →